United Capital Financial Advisors’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
59,908
+15,700
+36% +$370K 0.01% 647
2026
Q1
$661K Sell
44,208
-14,419
-25% -$246K ﹤0.01% 934
2025
Q4
$854K Buy
58,627
+114
+0.2% +$1.99K 0.01% 792
2025
Q3
$1.05M Buy
58,513
+38,780
+197% +$569K 0.01% 627
2025
Q2
$337K Sell
19,733
-247
-1% -$2.47K ﹤0.01% 891
2025
Q1
$145K Sell
19,980
-128
-0.6% -$1.46K ﹤0.01% 1035
2024
Q4
$283K Buy
20,108
+527
+3% +$7.79K ﹤0.01% 902
2024
Q3
$232K Buy
+19,581
New +$203K ﹤0.01% 956

Other funds holding CORZ

United Capital Financial Advisors's CORZ Position: Q2 2026 in Review

United Capital Financial Advisors increased its Core Scientific (CORZ) stake by 36% in Q2 2026, buying an estimated $370K and bringing the position to 59,908 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #647.

United Capital Financial Advisors first reported a position in CORZ in Q3 2024 and has held it in 8 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • United Capital Financial Advisors held 59,908 shares of Core Scientific worth $1.53M as of Q2 2026.
  • United Capital Financial Advisors bought 15,700 Core Scientific shares in Q2 2026, an estimated $370K.
  • Core Scientific made up 0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #647 holding.
  • United Capital Financial Advisors first reported a position in Core Scientific in Q3 2024 and has held it in 8 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.